US Patent 7960398 Regulation of TNF-alpha
Patent 7960398 was granted and assigned to Vertex Pharmaceuticals on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+469 characters)
Article
Patent abstract
The present invention relates to methods for identifying compounds useful for regulating TNF-alpha levels and/or activity. The invention also relates to methods for decreasing TNF-alpha levels and/or activity. Compounds and compositions according to this invention are useful for treating TNF-mediated diseases. The invention also relates to kits comprising the compounds and compositions herein and a tool for measuring TNF-alpha activity and/or levels.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07960398 Regulation of TNF-alpha US Patent 7960398 Regulation of TNF-alpha
Infobox
Patent Number
0796039800
Patent Number
796039800
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079603980
Date of Patent
June 14, 2011
0Patent Application Number
104193270
Date Filed
April 17, 2003
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079603980
Date of Patent
June 14, 2011
0Patent Application Number
104193270
Date Filed
April 17, 2003
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07960398 Regulation of TNF-alpha
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07960398
Date of patent
June 14, 2011
Patent application number
10419327
Date Filed
April 17, 2003
Patent primary examiner
Find more entities like US Patent 7960398 Regulation of TNF-alpha
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.